Clarivate Plc , a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch report, identifying eleven therapies expected to deliver significant clinical impact ...
Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient careLONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ...
Zacks Investment Research on MSN
LLY up 28% in 3 months: Is it the right time to invest in the stock?
Eli Lilly and Company’s LLY stock has risen 28% in the past three months. With exceptional growth from its GLP-1 drugs, ...
Individuals with incomplete and complete microscopic colitis share similar risk factors, demographics, and response to therapy.
Pfizer Inc.’s PFE promising ulcerative colitis treatment could generate $1.9 billion in sales by 2030 if it’s approved by U.S. regulators next year. That’s according to SVB Securities analyst David ...
Greater background mucosal inflammation was associated with poorer survival outcomes in patients with ulcerative colitis who ...
Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...
Gallbladder cancer is a rare and often aggressive malignancy that develops in the tissues of the gallbladder — a small, ...
Ulcerative colitis often develops in people aged 15-30 or 50-70. Exercise can reduce inflammation and strengthen the intestinal lining. A fecal occult blood test is a noninvasive test that can help ...
Ulcerative colitis causes bloody diarrhea, abdominal pain, and changes in bowel habits. UC flare-ups are worsened by stress, certain foods, and menstrual cycles. Other symptoms of UC include fever, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback